LL/2 In Vitro Light Microscopy-based Apoptosis Assay
CAT#: ITS-1022-YF768
Target Cell Organism: Mouse
Target Cell Alternative Name: LLC1
Target Cell Name: LL/2
Assay Type: Detection of Apoptosis Assays
Assay Overview
This assay is to provide LL/2-based In Vitro Light Microscopy-based Apoptosis Assay to accelerate our client's oncology projects. The assay will be customized according to the specific requirements. Please contact our scientists to discuss more details.
Target Cell Name
LL/2
Target Cell Organism
Mouse
Target Cell Background
LL/2 (LLC1) is a cell line established from the lung of a C57BL mouse bearing a tumor resulting from an implantation of primary Lewis lung carcinoma.
Target Cell Alternative Name
LLC1
Related Diseases
Lewis Lung Carcinoma
Research Area
Oncology
Assay Name
In Vitro Light Microscopy-based Apoptosis Assay
Short Description
LL/2-cell based In Vitro Light Microscopy-based Apoptosis Assay
Assay Description
For apoptosis-related morphological observations, light microscopy has widely been used. During apoptosis, changes in cell shape, volume, cell shrinkage and formation of apoptotic bodies can be clearly observed using light microscopy. Stains such as hematoxylin and eosin can be used to stain cancer cells before morphological observations under light microscopy. Although the light microscopy technique is an easy and inexpensive method, low sensitivity is the main disadvantage of this technique.
Assay Type
Detection of Apoptosis Assays
Assay Type Details
Apoptosis (programmed cell death) plays a vital role in embryonic development, homeostasis, functioning of immune system and wound repair. The ability to evade induction of apoptosis has been used by cancer cells to survive against host defense mechanisms. The molecular mechanisms involved in cancer cell apoptosis have been well documented and it involves certain biochemical events such as DNA fragmentation, chromatin condensation, cell organelle degradation and protein cleavage, etc. The extrinsic and intrinsic (mitochondrial) pathways are the two major pathways involved in apoptosis. With the available techniques and assays, a number of apoptosis inducing agents (natural compounds, synthetic compounds, nano-formulations, peptides and enzymes) in many cancer cells have been identified. Selection of an assay for apoptosis detection is based on factors such as apoptotic pathway, nature of drug, cell type being used and the method of analysis.